Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients-Reference-Cited by-同舟云学术

Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients

Published:2009-04-21 Issue:11 Volume:30 Page:1356-1363
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Raichlin E.,Prasad A.,Kremers W. K.,Edwards B. S.,Rihal C. S.,Lerman A.,Kushwaha S. S.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/30/11/1356/1798290/ehp123.pdf

Reference55 articles.

1. Task force 5: Complications

2. Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants

3. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Heart Transplant Report—2007

4. Responses of coronary arteries of cardiac transplant patients to acetylcholine.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of cardiac allograft vasculopathy complicated with coronary vasospasm: insights from near-infrared spectroscopy, intravascular ultrasound, and optical coherence tomography;European Heart Journal - Case Reports;2023-08-01

2. Cardiac Transplantation: Physiology and Natural History of the Transplanted Heart;Comprehensive Physiology;2023-06-26

3. Peripheral microvascular dysfunction is associated with plaque progression and adverse long‐term outcomes in heart transplant patients;ESC Heart Failure;2021-09-12

4. Circulating progenitor cells are associated with plaque progression and long-term outcomes in heart transplant patients;Cardiovascular Research;2021-06-16

5. Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy;Clinical Transplantation;2019-12-31